Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Lajos Homor"'
Autor:
Eva Karadi, Peter Dombi, Viktoria Gyorine Korom, Eszter Kovacs, Jozsef Herczeg, Hajnalka Andrikovics, Arpad Illes, Judit Demeter, Lajos Homor, Miklós Udvardy, Miklós Egyed
Publikováno v:
European Journal of Haematology.
Autor:
Judit Demeter, Miklos Egyed, Zsófia Simon, Zoltán Gasztonyi, Árpád Illés, József Herczeg, Péter Dombi, Lajos Homor, Éva Karádi, Viktoria Gy Korom, Miklós Udvardy, Ibolya Ercsei, László Szerafin, Ádám Kellner
Publikováno v:
European Journal of Haematology. 105:408-418
We report an extension study of patients with essential thrombocythaemia (ET) in the Hungarian Myeloproliferative Neoplasm (HUMYPRON) Registry, which demonstrated that over 6 years anagrelide significantly decreased the number of patients experiencin
Autor:
Árpád Illés, Judit Demeter, Erika Valasinyószki, Zsófia Simon, Miklos Egyed, Ádám Kellner, Lajos Homor, Miklós Udvardy, Péter Dombi, Éva Karádi
Publikováno v:
Orvosi Hetilap. 158:901-909
Abstract: Intruduction and aim: The Hungarian National Registry for Philadelphia chromosome negative myeloproliferative neoplasms has been developed. The aim of the recent study is to assess the clinical characteristics of Hungarian patients with pol
Autor:
Péter Dombi, Zsófia Simon, Miklos Egyed, Miklós Udvardy, Lajos Homor, Árpád Illés, Judit Demeter, Éva Karádi, Ádám Kellner
Publikováno v:
Orvosi Hetilap. 158:111-116
Abstract: Introduction: In order to establish and use a national registry, several Hungarian hematology centers collected data of myeloproliferative neoplasia patients. Aim: The recent publication is an analysis of the data of registered essential th
Autor:
Árpád Illés, Péter Dombi, Miklos Egyed, Miklós Udvardy, Lajos Homor, Zsófia Simon, Judit Demeter
Publikováno v:
Orvosi Hetilap. 157:98-103
Introduction: The establishment and operation of disease registry can be used to collect data on epidemiology cases. In addition, the registry can help to work out medical and health economical and political decisions for longer term. Aim: The aim of
Autor:
Éva Karádi, Hajnalka Andrikovics, Miklos Egyed, Lajos Homor, Péter Dombi, Miklós Udvardy, Ádám Kellner, Árpád Illés, Péter Rajnics, Judit Demeter, József Herczeg, Vasana S Kellner
Publikováno v:
Journal of Blood & Lymph.
Objectives: Thrombosis is a leading cause of morbidity and mortality in patients with Philadelphia negative chronic myeloproliferative neoplasms (MPNs). There are many thrombosis risk stratifications used in this patient group taking into considerati
Autor:
Péter, Dombi, Árpád, Illés, Judit, Demeter, Lajos, Homor, Zsófia, Simon, Ádám, Kellner, Éva, Karádi, Erika, Valasinyószki, Miklós, Udvardy, Miklós, Egyed
Publikováno v:
Orvosi hetilap. 158(23)
Intruduction and aim: The Hungarian National Registry for Philadelphia chromosome negative myeloproliferative neoplasms has been developed. The aim of the recent study is to assess the clinical characteristics of Hungarian patients with polycythemia
Autor:
Péter, Dombi, Árpád, Illés, Judit, Demeter, Lajos, Homor, Zsófia, Simon, Miklós, Udvardy, Éva, Karádi, Ádám, Kellner, Miklós, Egyed
Publikováno v:
Orvosi hetilap. 158(3)
In order to establish and use a national registry, several Hungarian hematology centers collected data of myeloproliferative neoplasia patients.The recent publication is an analysis of the data of registered essential thrombocythaemic patients.an onl
Autor:
Miklos Egyed, Judit Demeter, Éva Karádi, Lajos Homor, Péter Dombi, Árpád Illés, Zsófia Simon, Miklós Udvardy
Objective To evaluate the reduction of thrombotic events (TE) in patients with essential thrombocythaemia (ET) treated with anagrelide versus hydroxyurea + aspirin (HU+ASA). Methods A questionnaire was developed using 2008 WHO diagnostic criteria, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5b864b066fbad6017357df36b8f9396
Autor:
Miklos Egyed, Lajos Homor, Hajnalka Andrikovics, Zsófia Simon, Miklós Udvardy, Péter Dombi, Ádám Kellner, Árpád Illés, Judit Demeter
Publikováno v:
Journal of Clinical & Experimental Oncology.
Objective: The Hungarian National Registry for Philadelphia chromosome negative myeloproliferative neoplasms was used to assess the clinical characteristics of Hungarian patients with polycythemia vera. Methods: Data from 351 JAK2 V617F-positive pati